You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 021530


✉ Email this page to a colleague

« Back to Dashboard


NDA 021530 describes MELOXICAM, which is a drug marketed by Lupin Ltd, Novitium Pharma, Avondale Pharms, Aiping Pharm Inc, Anda Repository, Ascent Pharms Inc, Aurobindo Pharma, Chartwell Rx, Cipla, Corepharma, Cr Double Crane, Dr Reddys Labs Inc, Glenmark Pharms Ltd, Impax Labs Inc, Lupin Pharms, Mylan, Natco Pharma, Puracap Pharm, Roxane, Strides Pharma, Sun Pharm Inds Inc, Taro, Unichem, Yabao Pharm, Yung Shin Pharm, and Zydus Pharms Usa, and is included in twenty-six NDAs. It is available from forty-six suppliers. Additional details are available on the MELOXICAM profile page.

The generic ingredient in MELOXICAM is meloxicam. There are twenty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
Summary for 021530
Tradename:MELOXICAM
Applicant:Avondale Pharms
Ingredient:meloxicam
Patents:0
Pharmacology for NDA: 021530
Mechanism of ActionCyclooxygenase Inhibitors
Suppliers and Packaging for NDA: 021530
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MELOXICAM meloxicam SUSPENSION;ORAL 021530 NDA Avondale Pharmaceuticals, LLC 71740-339 71740-339-11 1 BOTTLE, PLASTIC in 1 CARTON (71740-339-11) / 100 mL in 1 BOTTLE, PLASTIC
MELOXICAM meloxicam SUSPENSION;ORAL 021530 NDA AUTHORIZED GENERIC Emerald Therapeutics, LLC 72919-124 72919-124-10 1 BOTTLE, PLASTIC in 1 CARTON (72919-124-10) / 100 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength7.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Jun 1, 2004TE:RLD:Yes

Expired US Patents for NDA 021530

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Avondale Pharms MELOXICAM meloxicam SUSPENSION;ORAL 021530-001 Jun 1, 2004 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.